Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.22B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Danaher
DHR
|
+$293M |
| 4 |
Linde
LIN
|
+$281M |
| 5 |
Carlyle Group
CG
|
+$268M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$926M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$770M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$649M |
| 4 |
Meta Platforms (Facebook)
META
|
+$641M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$462M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.07% |
| 2 | Financials | 9% |
| 3 | Technology | 7.77% |
| 4 | Healthcare | 6.87% |
| 5 | Industrials | 5.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4426
PUT
Immunovant
IMVT
$8.51B
| $769K | ﹤0.01% |
+45,000
| New | +$941K |
|
|
SGMO
4427
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $769K | ﹤0.01% |
1,172,092
-1,567,574
| -57% | -$1.66M |
|
4428
Titan International
TWI
$453M
| $765K | ﹤0.01% |
91,174
+48,451
| +113% | +$401K |
|
4429
S&T Bancorp
STBA
$1.76B
| $765K | ﹤0.01% |
20,645
-12,250
| -37% | -$471K |
|
4430
Amplify Junior Silver Miners ETF
SILJ
$4.2B
| $764K | ﹤0.01% |
63,000
-130,500
| -67% | -$1.47M |
|
4431
CALL
Insmed
INSM
$25.9B
| $763K | ﹤0.01% |
10,000
-61,900
| -86% | -$4.73M |
|
4432
Werewolf Therapeutics
HOWL
$45.8M
| $763K | ﹤0.01% |
784,617
+188,328
| +32% | +$247K |
|
4433
Vanguard Total International Stock ETF
VXUS
$163B
| $762K | ﹤0.01% |
+12,278
| New | +$758K |
|
4434
PUT
Watsco Inc
WSO
$12.8B
| $762K | ﹤0.01% |
1,500
-5,600
| -79% | -$2.76M |
|
4435
PUT
Maplebear
CART
$11.7B
| $762K | ﹤0.01% |
19,100
-44,800
| -70% | -$1.99M |
|
4436
Vanguard Total International Bond ETF
BNDX
$82.5B
| $761K | ﹤0.01% |
15,580
-151
| -1% | -$7.38K |
|
|
NEXN
4437
Nexxen International
NEXN
$583M
| $760K | ﹤0.01% |
91,005
-7,737
| -8% | -$69.8K |
|
4438
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.52B
| $758K | ﹤0.01% |
20,964
+12,583
| +150% | +$458K |
|
4439
CEVA Inc
CEVA
$764M
| $758K | ﹤0.01% |
29,587
-39,690
| -57% | -$1.28M |
|
4440
OceanFirst Financial
OCFC
$1.82B
| $756K | ﹤0.01% |
44,433
-116,404
| -72% | -$2.07M |
|
4441
CALL
Indivior Pharmaceuticals
INDV
$4.12B
| $756K | ﹤0.01% |
+79,300
| New | +$834K |
|
4442
PUT
Coupang
CPNG
$29.7B
| $752K | ﹤0.01% |
34,300
-68,000
| -66% | -$1.58M |
|
4443
CALL
ZIM Integrated Shipping Services
ZIM
$3.31B
| $751K | ﹤0.01% |
51,500
+25,700
| +100% | +$483K |
|
4444
CALL
Clorox
CLX
$12.4B
| $751K | ﹤0.01% |
5,100
-147,800
| -97% | -$22.6M |
|
|
GTLS
4445
CALL
DELISTED
Chart Industries
GTLS
| $751K | ﹤0.01% |
+5,200
| New | +$958K |
|
4446
Merchants Bancorp
MBIN
$2.45B
| $750K | ﹤0.01% |
20,282
-105,805
| -84% | -$4.17M |
|
4447
Caribou Biosciences
CRBU
$174M
| $750K | ﹤0.01% |
821,051
-38,774
| -5% | -$50.4K |
|
4448
Aquestive Therapeutics
AQST
$630M
| $749K | ﹤0.01% |
258,216
+170,989
| +196% | +$518K |
|
4449
Allot
ALLT
$381M
| $748K | ﹤0.01% |
131,075
+17,465
| +15% | +$122K |
|
|
AVDL
4450
DELISTED
Avadel Pharmaceuticals
AVDL
| $747K | ﹤0.01% |
95,378
-1,116,626
| -92% | -$9.35M |
|
Similar funds
Israel Englander's Q1 2025 Portfolio in Review
As of Q1 2025, Israel Englander held 6,639 positions worth $188B, down 8.2% from $205B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Israel Englander withdrew a net $10.2B in Q1 2025, closing 852 positions and reducing 2,261 holdings. Its most notable exit was Verizon, an estimated $263M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 50% a quarter earlier, followed by Financials and Technology.
Against the trend, Israel Englander opened a new position in Blackrock worth $215M.
- Israel Englander's largest Q1 2025 buy was Blackrock: 227,394 shares worth $215M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q1 2025, an estimated $2.22B increase.
- Israel Englander's biggest Q1 2025 reduction was Broadcom, cutting an estimated $926M.
- Israel Englander fully exited Verizon in Q1 2025, selling an estimated $263M.
- Israel Englander's ten largest holdings make up 16% of its $188B portfolio in Q1 2025.
- Israel Englander opened 739 new positions and closed 852 in Q1 2025.
- Israel Englander's portfolio value fell 8.2% quarter-over-quarter to $188B.
Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.